Hansen KB, Svendstrup M, Lund A, Knop FK, et al. Once-weekly subcutaneous semaglutide treatment for persons with type 2 diabetes: real-world data from a diabetes out-patient clinic. Diabet Med 2021 Jul 22:e14655. doi: 10.1111/dme.14655.
PMID: 34291491